TITLE

The Potency of Refined Mouse Models: Implications for Clinical Trials

AUTHOR(S)
Graeser, Ralph; Fiedler, Ulrike; Esser, Norbert; Klotzbuecher, Andrea; Weber, Holger; Schaechtele, Christoph
PUB. DATE
February 2010
SOURCE
Current Cancer Therapy Reviews;2010, Vol. 6 Issue 1, p62
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Many promising anti-cancer compounds fail in the clinical phase despite extensive testing in animal models. Reasons for this failure are varied, ranging from inadequate mouse models to dosing schemes that cannot be applied in humans. The apparent shortcomings of exisiting pre-clinical studies suggests a need for improved mouse models. Furthermore, the development of an increasing number of targeted drugs requires that biomarkers and/or the in vivo imaging of the tumor or its environment need to be established, ideally before the clinical candidate is selected. In this review, we focus on recent progress in mouse models, emphasizing imaging techniques, biomarker development, the tumor microenvironment and orthotopic metastatic tumor models. We discuss the application of the latter models to drug testing, making comparisons with classical subcutaneous xenograft models, and also models utilizing transgenic animals. Imaging modalities used to detect orthotopically implanted cells in the mouse, e.g. fluorescence or luciferase, which allow relatively high throughput measurements, will be compared to PET, CT, or MRI, which are closer to the clinical application. Examples for a combination of the latter imaging systems with luciferase or fluorescence in the mouse to develop or improve clinical imaging will be presented. Finally, the value of biomarkers in mouse models and strategies to identify novel targetspecific biomarkers in mouse models will be discussed.
ACCESSION #
53020239

 

Related Articles

  • Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Wang, Timothy C.; Cardiff, Robert D. // Nature;6/23/1994, Vol. 369 Issue 6482, p669 

    Examines the consequences of overexpression of cyclin D1 in transgenic mice. Central role for cyclins in growth control; Abnormal mammary cell proliferation; Development of mammary adenocarcinomas; Oncogenic role in breast cancer.

  • Million-dollar mice.  // New Internationalist;Dec2000, Issue 330, p7 

    Reports on the attention attracted the alleged most expensive variety of a transgenic mouse, the TG2576 or the Hsaio Mouse. Alteration of the mouse's gene to contract Alzheimer's disease; Cost benefits derived from the transgenic mouse in terms of research costs.

  • Keratins in health and cancer: more than mere epithelial cell markers. Karantza, V // Oncogene;1/13/2011, Vol. 30 Issue 2, p127 

    Keratins are the intermediate filament (IF)-forming proteins of epithelial cells. Since their initial characterization almost 30 years ago, the total number of mammalian keratins has increased to 54, including 28 type I and 26 type II keratins. Keratins are obligate heteropolymers and, similarly...

  • Validation of the Cardiosphere Method to Culture Cardiac Progenitor Cells from Myocardial Tissue. Davis, Darryl R.; Yiqiang Zhang; Smith, Rachel R.; Ke Cheng; Terrovitis, John; Malliaras, Konstantinos; Tao-Sheng Li; White, Anthony; Makkar, Raj; Marbán, Eduardo // PLoS ONE;2009, Vol. 4 Issue 9, p1 

    Background: At least four laboratories have shown that endogenous cardiac progenitor cells (CPCs) can be grown directly from adult heart tissue in primary culture, as cardiospheres or their progeny (cardiosphere-derived cells, CDCs). Indeed, CDCs are already being tested in a clinical trial for...

  • Spare the mice. Walker, Matt // New Scientist;07/26/97, Vol. 155 Issue 2092, p5 

    Cites toxicologist Michael Festing's call for use of inbred strains of mice in toxicology experiments. Data noise brought by using outbred strains; Need to reduce the number of rodents used in toxicity.

  • Science & Super Mice. Rowley, Brian // Joe Weider's Muscle & Fitness;Jul2002, Vol. 63 Issue 7, p80 

    Examines the impact of the transgenic growth factor on bodybuilding science. Details of the work done on genetically engineered strain of super mice; Percentage of mice that experienced increase in muscle mass; Link between stimulus and growth.

  • Might mammalian mitochondria merge? Turnbull, Douglass M.; Lightowlers, Robert N. // Nature Medicine;Aug2001, Vol. 7 Issue 8, p895 

    Reports on the development of a transgenic mouse model carrying pathogenic mitochondria DNA. Scarcity of evidence for the dynamic nature of mammalian mitochondria; Background on mitochondrial DNA diseases as a group of genetic disorders.

  • Hippocampal immunostaining of CCK-GAD1 transgenic mice. Schmidt, M J; Horvath, S; Ebert, P; Norris, J L; Seeley, E H; Brown, J; Gellert, L; Everheart, M; Garbett, K A; Grice, T W; Caprioli, R M; Mirnics, K // Molecular Psychiatry;May2014, Vol. 19 Issue 5, p529 

    An image is presented depicting the Hippocampal CA3 region triple-immunostaining in transgenic mice.

  • Reduced troponin I phosphorylation and increased Ca2+-dependent ATP-consumption in triton X-skinned fiber preparations from Gαq overexpressor mice. C. Pott; L. Willkomm; S. Grafweg; B. Bölck; G. Dorn; R. Schwinger; K. Brixius // Molecular & Cellular Biochemistry;Jul2008, Vol. 314 Issue 1/2, p133 

    Abstract  Overexpression of the Gαq-protein has been shown to result in hypertrophic and dilated cardiomyopathy. This study investigated Ca2+ sensitivity of tension and myosin-ATPase activity in skinned fiber preparations of male and female wildtype (WT; n = 12) and transgenic...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics